Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 17/20 | 0.73 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.58 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8423870 | 0.92 | PTGS2 (0.79) | PTGS2PTGS1AOC3 | |
| SCHEMBL8423953 | 0.92 | PTGS2 (0.79) | PTGS2PTGS1AOC3 | |
| SCHEMBL8420804 | 0.90 | PTGS2 (0.88) | PTGS2PTGS1CYP2C9ALOX5 | |
| SCHEMBL8420952 | 0.90 | PTGS2 (0.69) | PTGS2PTGS1AOC3CYP2C9ALOX5 | |
| SCHEMBL8420090 | 0.89 | PTGS2 (0.78) | PTGS2PTGS1CYP2C9ALOX5 | |
| SCHEMBL8421495 | 0.89 | PTGS2 (0.67) | PTGS2PTGS1AOC3CYP2C9 | |
| SCHEMBL8127713 | 0.88 | PTGS2 (0.73) | PTGS2PTGS1CYP2C9 | |
| SCHEMBL8421887 | 0.88 | PTGS2 (0.73) | PTGS2PTGS1CYP2C9ALOX5 | |
| SCHEMBL8422330 | 0.88 | PTGS2 (0.69) | PTGS2PTGS1CYP2C9ALOX5 | |
| SCHEMBL8423987 | 0.87 | PTGS2 (0.75) | PTGS2PTGS1CYP2C9ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5908852-A | 1,3,5 trisubstituted pyrazole compounds for treatment of inflammation | G. D. SEARLE & CO. (US) | 1999-06-01 | — | — | US | disclosed |
| US-5434178-A | 1,3,5 trisubstituted pyrazole compounds for treatment of inflammation | G.D. SEARLE & CO. (US) | 1995-07-18 | — | — | US | disclosed |